A clinicopathological study on adenocarcinoma of the uterine cervix
A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2%...
Gespeichert in:
| Veröffentlicht in: | Nihon Sanka Fujinka Gakkai zasshi 1991-03, Vol.43 (3), p.261-265 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 265 |
|---|---|
| container_issue | 3 |
| container_start_page | 261 |
| container_title | Nihon Sanka Fujinka Gakkai zasshi |
| container_volume | 43 |
| creator | Yoshida, K Okuda, H Hayashi, Y Nakagiri, Y Sekiba, K |
| description | A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2% (11/42). There was no difference between the rate of lymph node involvement in adenocarcinoma and squamous cell carcinoma. The 5-year survival rates were as follows: stage I 83.3% (25/30), stage II 58.1% (18/31), stage III (0/4), stage IV (2/5), and all stages 64.3% (45/70). The 5-year survival rate for patients with adenocarcinoma was poor in contrast to that for patients with squamous cell carcinoma (p less than 0.05). It was suggested that adenocarcinoma was less radiosensitive than squamous cell carcinoma. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80603778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80603778</sourcerecordid><originalsourceid>FETCH-LOGICAL-p121t-318c76b49d88ed84064ca3005e01ec69df364cbd84bdef2bd04544536e4aca03</originalsourceid><addsrcrecordid>eNotj8lqwzAYhHVoSUOaRyjo1JtBthbLx2C6QaCX3I2W341AllxJLs3b11CfBmY-hpk7tCeUkKqrBX9Ax5ydJoTLtms526FdQxgXHduj_oSNd8GZOKtyjT5-OaM8zmWxNxwDVhZCNCoZF-KkcBxxuQJeCiQXABtIP-73Ed2Pymc4bnpAl9eXS_9enT_fPvrTuZrrpi4VraVphWadlRKsZEQwo9aNHEgNRnR2pKuj10RbGBtt142McSqAKaMIPaDn_9o5xe8Fchkmlw14rwLEJQ-SCELbVq7g0wYuegI7zMlNKt2G7TT9AxjrU2I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80603778</pqid></control><display><type>article</type><title>A clinicopathological study on adenocarcinoma of the uterine cervix</title><source>MEDLINE</source><source>Freely Accessible Japanese Titles</source><creator>Yoshida, K ; Okuda, H ; Hayashi, Y ; Nakagiri, Y ; Sekiba, K</creator><creatorcontrib>Yoshida, K ; Okuda, H ; Hayashi, Y ; Nakagiri, Y ; Sekiba, K</creatorcontrib><description>A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2% (11/42). There was no difference between the rate of lymph node involvement in adenocarcinoma and squamous cell carcinoma. The 5-year survival rates were as follows: stage I 83.3% (25/30), stage II 58.1% (18/31), stage III (0/4), stage IV (2/5), and all stages 64.3% (45/70). The 5-year survival rate for patients with adenocarcinoma was poor in contrast to that for patients with squamous cell carcinoma (p less than 0.05). It was suggested that adenocarcinoma was less radiosensitive than squamous cell carcinoma.</description><identifier>ISSN: 0300-9165</identifier><identifier>PMID: 2045694</identifier><language>jpn</language><publisher>Japan</publisher><subject>Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Female ; Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis ; Radiation Tolerance ; Survival Rate ; Uterine Neoplasms - mortality ; Uterine Neoplasms - pathology</subject><ispartof>Nihon Sanka Fujinka Gakkai zasshi, 1991-03, Vol.43 (3), p.261-265</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2045694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshida, K</creatorcontrib><creatorcontrib>Okuda, H</creatorcontrib><creatorcontrib>Hayashi, Y</creatorcontrib><creatorcontrib>Nakagiri, Y</creatorcontrib><creatorcontrib>Sekiba, K</creatorcontrib><title>A clinicopathological study on adenocarcinoma of the uterine cervix</title><title>Nihon Sanka Fujinka Gakkai zasshi</title><addtitle>Nihon Sanka Fujinka Gakkai Zasshi</addtitle><description>A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2% (11/42). There was no difference between the rate of lymph node involvement in adenocarcinoma and squamous cell carcinoma. The 5-year survival rates were as follows: stage I 83.3% (25/30), stage II 58.1% (18/31), stage III (0/4), stage IV (2/5), and all stages 64.3% (45/70). The 5-year survival rate for patients with adenocarcinoma was poor in contrast to that for patients with squamous cell carcinoma (p less than 0.05). It was suggested that adenocarcinoma was less radiosensitive than squamous cell carcinoma.</description><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Radiation Tolerance</subject><subject>Survival Rate</subject><subject>Uterine Neoplasms - mortality</subject><subject>Uterine Neoplasms - pathology</subject><issn>0300-9165</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotj8lqwzAYhHVoSUOaRyjo1JtBthbLx2C6QaCX3I2W341AllxJLs3b11CfBmY-hpk7tCeUkKqrBX9Ax5ydJoTLtms526FdQxgXHduj_oSNd8GZOKtyjT5-OaM8zmWxNxwDVhZCNCoZF-KkcBxxuQJeCiQXABtIP-73Ed2Pymc4bnpAl9eXS_9enT_fPvrTuZrrpi4VraVphWadlRKsZEQwo9aNHEgNRnR2pKuj10RbGBtt142McSqAKaMIPaDn_9o5xe8Fchkmlw14rwLEJQ-SCELbVq7g0wYuegI7zMlNKt2G7TT9AxjrU2I</recordid><startdate>199103</startdate><enddate>199103</enddate><creator>Yoshida, K</creator><creator>Okuda, H</creator><creator>Hayashi, Y</creator><creator>Nakagiri, Y</creator><creator>Sekiba, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199103</creationdate><title>A clinicopathological study on adenocarcinoma of the uterine cervix</title><author>Yoshida, K ; Okuda, H ; Hayashi, Y ; Nakagiri, Y ; Sekiba, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p121t-318c76b49d88ed84064ca3005e01ec69df364cbd84bdef2bd04544536e4aca03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1991</creationdate><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Radiation Tolerance</topic><topic>Survival Rate</topic><topic>Uterine Neoplasms - mortality</topic><topic>Uterine Neoplasms - pathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Yoshida, K</creatorcontrib><creatorcontrib>Okuda, H</creatorcontrib><creatorcontrib>Hayashi, Y</creatorcontrib><creatorcontrib>Nakagiri, Y</creatorcontrib><creatorcontrib>Sekiba, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Nihon Sanka Fujinka Gakkai zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshida, K</au><au>Okuda, H</au><au>Hayashi, Y</au><au>Nakagiri, Y</au><au>Sekiba, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A clinicopathological study on adenocarcinoma of the uterine cervix</atitle><jtitle>Nihon Sanka Fujinka Gakkai zasshi</jtitle><addtitle>Nihon Sanka Fujinka Gakkai Zasshi</addtitle><date>1991-03</date><risdate>1991</risdate><volume>43</volume><issue>3</issue><spage>261</spage><epage>265</epage><pages>261-265</pages><issn>0300-9165</issn><abstract>A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2% (11/42). There was no difference between the rate of lymph node involvement in adenocarcinoma and squamous cell carcinoma. The 5-year survival rates were as follows: stage I 83.3% (25/30), stage II 58.1% (18/31), stage III (0/4), stage IV (2/5), and all stages 64.3% (45/70). The 5-year survival rate for patients with adenocarcinoma was poor in contrast to that for patients with squamous cell carcinoma (p less than 0.05). It was suggested that adenocarcinoma was less radiosensitive than squamous cell carcinoma.</abstract><cop>Japan</cop><pmid>2045694</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-9165 |
| ispartof | Nihon Sanka Fujinka Gakkai zasshi, 1991-03, Vol.43 (3), p.261-265 |
| issn | 0300-9165 |
| language | jpn |
| recordid | cdi_proquest_miscellaneous_80603778 |
| source | MEDLINE; Freely Accessible Japanese Titles |
| subjects | Adenocarcinoma - mortality Adenocarcinoma - pathology Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Female Humans Lymphatic Metastasis Neoplasm Staging Prognosis Radiation Tolerance Survival Rate Uterine Neoplasms - mortality Uterine Neoplasms - pathology |
| title | A clinicopathological study on adenocarcinoma of the uterine cervix |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A12%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20clinicopathological%20study%20on%20adenocarcinoma%20of%20the%20uterine%20cervix&rft.jtitle=Nihon%20Sanka%20Fujinka%20Gakkai%20zasshi&rft.au=Yoshida,%20K&rft.date=1991-03&rft.volume=43&rft.issue=3&rft.spage=261&rft.epage=265&rft.pages=261-265&rft.issn=0300-9165&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E80603778%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80603778&rft_id=info:pmid/2045694&rfr_iscdi=true |